December 5, 2017December 5, 2017 Biocon Biosimilar, Innovation Biocon’s Landmark Achievement of First USFDA approval for Biosimilar Trastuzumab applauded by all including the Media First Biosimilar Trastuzumab approved in the US
A Blog by Biocon 